Crestor Patient Assistance Programs
Crestor (rosuvastatin), made by AstraZeneca, offers assistance through the AstraZeneca Patient Assistance Program (AZ&PAP) for uninsured or underinsured U.S. patients. Eligibility hinges on household income, lack of prescription coverage, and U.S. residency. Patients must meet income limits, typically at or below 400-600% of the federal poverty level (FPL), depending on the specific program tier and household size.[1][2]
Current Income Guidelines for AZ&PAP
For Crestor, full free medication requires annual household income under these thresholds (2024 FPL-based, adjusted yearly):
- 1-person household: Up to $60,000
- 2-person: Up to $81,000
- 3-person: Up to $102,000
- 4-person: Up to $123,000
- Add $20,400 per additional person
Higher limits (up to 700% FPL, or ~$90,000 for one person) apply if you have insurance but face high copays. Medicare patients qualify separately via AZ&Me, often up to 400% FPL with no income cap if copays exceed $50/month.[1][3]
| Household Size | Max Income (Full Free Meds) | Max Income (Copay Help) |
|----------------|-----------------------------|--------------------------|
| 1 | $60,000 | $90,000+ |
| 2 | $81,000 | $109,000+ |
| 3 | $102,000 | $137,000+ |
| 4 | $123,000 | $165,000+ |
How to Check and Apply
Visit AstraZeneca's site or call 1-800-AZANDME (1-800-292-6363) to verify exact limits, as they update with FPL changes (e.g., January 2025). Submit proof of income, residency, and insurance status online or by mail. Approval takes 2-4 weeks; meds ship for up to 12 months, renewable.[2]
Alternatives if Income Is Too High